Listen to expert insights from Joseph J. Eron, Jr., MD, and Daniel R. Kuritzkes, MD, on evolving considerations for first-line HIV therapy, including 2-drug regimens, weight gain, and pregnancy safety.
In this episode, Joseph J. Eron, Jr., MD; and Daniel R. Kuritzkes, MD; discuss evolving issues in first-line antiretroviral therapy, including 2-drug therapy, weight gain, and safety during conception and pregnancy.
Presenters:
Joseph J. Eron, Jr., MD
Professor of Medicine and Epidemiology
University of North Carolina
School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina
Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women’s Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Content based on an online CME program supported by an independent educational grant from ViiV Healthcare.
Link to full program:
http://bit.ly/34fVILZ